Dynavax Technologies Corporation
DVAX
$10.31
-$0.34-3.19%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 7.05M | 17.59M | 11.39M | -8.72M | 219.00K |
| Total Depreciation and Amortization | 2.07M | 2.05M | 1.98M | 1.95M | 1.96M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.16M | 11.35M | 8.46M | 16.21M | 4.94M |
| Change in Net Operating Assets | 32.73M | -11.54M | -11.11M | -26.12M | 6.65M |
| Cash from Operations | 53.01M | 19.47M | 10.71M | -16.68M | 13.77M |
| Capital Expenditure | -3.48M | -1.35M | -779.00K | -749.00K | -1.72M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 26.84M | -14.12M | -27.99M | 3.58M | -18.52M |
| Cash from Investing | 23.37M | -15.47M | -28.77M | 2.83M | -20.24M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.60M | 2.73M | 419.00K | 2.54M | 2.02M |
| Repurchase of Common Stock | -100.48M | -251.00K | -1.83M | -6.74M | -245.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.88M | 2.48M | -1.42M | -4.20M | 1.78M |
| Foreign Exchange rate Adjustments | -960.00K | 363.00K | -64.00K | -201.00K | 479.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.46M | 6.84M | -19.53M | -18.25M | -4.22M |